# Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential

- Frédéric Chalmel
^{1}Email author,### Affiliated with

- Thierry Léveillard
^{2}Email author,### Affiliated with

- Céline Jaillard
^{2}Email author,### Affiliated with

- Aurélie Lardenois
^{3}Email author,### Affiliated with

- Naomi Berdugo
^{2, 8}Email author,### Affiliated with

- Emmanuelle Morel
^{2}Email author,### Affiliated with

- Patrice Koehl
^{4}Email author,### Affiliated with

- George Lambrou
^{5}Email author,### Affiliated with

- Arne Holmgren
^{6}Email author,### Affiliated with

- José A Sahel
^{2, 7}Email author and### Affiliated with

- Olivier Poch
^{3}Email author### Affiliated with

**8**:74

**DOI: **10.1186/1471-2199-8-74

© Chalmel et al; licensee BioMed Central Ltd. 2007

**Received: **08 January 2007

**Accepted: **31 August 2007

**Published: **31 August 2007